Image from medicaldialogues.in: A New Genetic Test Could Help Solve Diabetes Diagnosis Puzzles
medicaldialogues.in (via medicaldialogues.in) / Source publication — credited and linked
Diagnosis & Early Detection/August 21, 2026/2 min read

A New Genetic Test Could Help Solve Diabetes Diagnosis Puzzles

Researchers found that adding a Type 1 diabetes genetic risk score to standard MODY testing can identify Type 1 diabetes in patients who previously received unclear results. This approach may lead to faster, more accurate diagnoses.

News report — unverified, pending corroboration

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

diagnosisscreeningstaging

Key takeaways

  • About 1 in 5 patients tested for MODY (a different form of diabetes) who received negative results actually have Type 1 diabetes, according to a new study
  • A genetic risk score designed for Type 1 diabetes can be added to existing MODY genetic tests to catch these cases
  • Better diagnosis could mean patients get clearer answers about their diabetes type instead of remaining genetically unexplained
  • This combined testing approach may reduce the need for additional, repeated investigations

The Diagnosis Challenge

When someone is diagnosed with diabetes, doctors sometimes need to figure out exactly which type they have. Maturity-onset diabetes of the young (MODY) is a rare genetic form that can look similar to Type 1 diabetes, especially early on. To tell them apart, doctors often use genetic testing.

The problem: some patients test negative for MODY but still don't have a clear explanation for their diabetes. They're left in a diagnostic gray zone—their diabetes is real, but the genetic cause remains a mystery.

What the Research Found

A study published in Diabetes Care examined whether adding a Type 1 diabetes genetic risk score to routine MODY testing could help solve this puzzle. The results were striking: among patients who tested negative for MODY, roughly 1 in 5 actually carried genetic risk markers for Type 1 diabetes.

This means these patients may have had Type 1 diabetes all along, but standard MODY-only testing missed it.

Why This Matters

Accurate diagnosis is foundational to good diabetes care. Knowing whether someone has Type 1 diabetes versus another form helps guide treatment decisions and patient education.

The combined testing approach offers several potential benefits: it improves diagnostic accuracy, reduces the need for patients to undergo multiple rounds of genetic testing, and most importantly, provides clearer answers. Instead of a diagnosis that leaves questions unanswered, patients and their families gain clarity about what type of diabetes they're managing.

Looking Ahead

This research suggests that genetic testing strategies can be refined to catch more cases of Type 1 diabetes earlier in the diagnostic process. While this is one study, the findings point toward a practical way to improve how we identify and classify diabetes in people who receive inconclusive results.

Evidence label

Origin: medicaldialogues.in (News report). Evidence: News report — unverified, pending corroboration. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.